NCT07325110 Interoceptive Awareness and Function in Adolescents With Chronic Pain
| NCT ID | NCT07325110 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Connecticut Children's Medical Center |
| Condition | Chronic Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 49 participants |
| Start Date | 2026-02-25 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 49 participants in total. It began in 2026-02-25 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objectives of this study are to compare the levels of interoceptive awareness and self-reported function pre and post completion of an occupational therapy treatment plan. The target population are adolescents aged 11-21 years that are diagnosed with chronic pain and are seen through the Pain Team at Connecticut Children's. The primary aims are: * To compare the reported levels of interoceptive awareness in adolescents with chronic pain before and after their occupational therapy treatment plan. * To compare the reported levels of function in adolescents with chronic pain before and after their occupational therapy treatment plan.
Eligibility Criteria
Study Group: Inclusion Criteria: 1. Adolescents seen as new patients in the pain clinic at Connecticut Children's 2. Referred to occupational therapy services. 3. Adolescents diagnosed with a form of chronic pain. 4. Between the ages of 11 and 21 years at time of enrollment. 5. If over 18, the ability to understand and willingness to sign the informed consent document or the ability to use the short form process. 6. If under 18, the parent/legal guardian, has the ability to understand and willingness to sign the informed consent document or the ability to use the short form process. 7. Adolescents between the ages of 11 and less than 18 years with the ability to understand and willingness to sign assent. 8. Adolescents who agree to therapeutic yoga as a planned part of their occupational therapy treatment plan. Exclusion Criteria: 1. Adolescents not receiving yoga as an element of their occupational therapy treatment plan. 2. Adolescents with a cognitive impairment that would impede their ability to participate. 3. Adolescents with a neuromuscular diagnosis, such as Cerebral Palsy, Spinal Muscular Atrophy, and Muscular Dystrophies, that are not appropriate for yoga as an element of their treatment plan for this study. 4. Adolescents unwilling to complete surveys to participate in this research study. 5. Adolescents who are currently actively practicing yoga 6. Adolescents who are currently receiving occupational therapy at another location.
Contact & Investigator
Allison Fell, BS
PRINCIPAL INVESTIGATOR
Connecticut Children's Medical Center
Frequently Asked Questions
Who can join the NCT07325110 clinical trial?
This trial is open to participants of all sexes, aged 11 Years or older, up to 21 Years, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07325110 currently recruiting?
Yes, NCT07325110 is actively recruiting participants. Contact the research team at IAandFunctionStudy@connecticutchildrens.org for enrollment information.
Where is the NCT07325110 trial being conducted?
This trial is being conducted at Hartford, United States.
Who is sponsoring the NCT07325110 clinical trial?
NCT07325110 is sponsored by Connecticut Children's Medical Center. The principal investigator is Allison Fell, BS at Connecticut Children's Medical Center. The trial plans to enroll 49 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.